U.S. jury orders AbbVie to pay $3 million in AndroGel retrial

NEW YORK (Reuters) - A U.S. jury on Monday ordered AbbVie Inc to pay more than $3 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, though the jury did not find AbbVie strictly liable.

from Reuters: U.S. https://ift.tt/2IW24EY

If You Enjoyed This, Take 5 Seconds To Share It

• 
• 
• 
• 
• 
•